Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tailored dosage of chemotherapy effective in treating breast cancer

16.12.2003


By tailoring the dosage of chemotherapy to each individual patient, the treatment of breast cancer could be improved considerably. This is shown in a dissertation by Uppsala researcher Henrik Lindman at Uppsala University in Sweden. The method has proven to yield excellent results in clinical tests.



The dissertation reports that an alternative way of tailoring the dosage of chemotherapy has been studied and found to work. If the advantages of this method compared to standard treatment can be verified in the follow-up study that has just been completed on more than 1,500 patients in Sweden and Denmark, we may be facing a more extensive change in the treatment of cancer, one that reaches far beyond the sphere of breast cancer. One clear advantage of the method, apart from fewer side-effects and less risk of under-dosage, is that it should provide a way of determining the value of new chemotherapies, since it is probable that tailored dosages will prevent improper dosage regimens to a greater extent than previously.

In treating cancer, the dosage of chemotherapy is normally determined on the basis of the body surface area of the patient, which factors in height and weight. This method has proven to be insufficient when it comes to differences among patients in the amount of chemotherapy in the blood. Some patients receive overdoses with severe side-effects as a result, while others receive under-dosed regimens that risk leaving the tumor insufficiently treated.


Henrik Lindman has studied a method of tailoring just the right dosage for each patient. This is done by measuring the decline in, above all, white corpuscles after each treatment and thereafter adjusting the following treatment. The method proved successful in the three different pioneering trials on women with breast cancer. The differences in tolerated chemotherapy were up to a factor of three across different patients, which, among other things, may be dependent on genetic differences in sensitivity. In a Nordic collaborative project, 525 women with breast cancer at high risk of recurrence were selected for treatment. Half of the patients received 9 doses of tailored treatment while the other half received high-dosage regimens with bone-marrow transplants after three standard dosages of chemotherapy. Patients receiving tailored treatment experienced a lower rate of recurrence of breast cancer (28% compared with 37% after 3 years).

The other two studies involved, respectively, 26 and 44 patients with metastasized breast cancer. Here, too, the effect of treatment was good in comparison with previous experience (81% and 63%, respectively, saw a dramatic reduction in their tumors). Women who could withstand the highest dosages did not experience more general side-effects than those who were given lower dosages.

Anneli Waara | alfa
Further information:
http://www.uu.se

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Polymers Based on Boron?

18.01.2018 | Life Sciences

Bioengineered soft microfibers improve T-cell production

18.01.2018 | Life Sciences

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>